As a child, stocks drew me more than pretty girls: Jhunjhunwala"I was enthralled more by fluctuating stock prices than pretty girls," Rakesh Jhunjhunwala told Bollywood star Alia Bhatt in a special one-on-one.
Rakesh Jhunjhunwala, as per the latest September 2017 filings, has put more money in Fortis Healthcare, Prakash Industries and Lupin Limited. Fortis Healthcare received investments from Rekha Jhunjhunwala, when she had first picked up a 0.9% stake in the company for an estimated Rs 60 crores, through an open market transaction in August - a holding which has now jumped to 1.54%.
Iron and steel company Prakash Industries had been in the news early August after SEBI added it to a list of shell companies, restricting its trading. But the restriction was later stayed and trading in the company resumed. Since then, Prakash Industries' share price has been trending up and got a boost today with news of Jhunjhunwala's increased investment in the stock. Pharma companyLupin Limited is another stock in which Jhunjhunwala's stake has increased, from 1.76% in June to 1.89% in September.
Superstar investor Rakesh Jhunjhunwala, whose portfolio net worth is well over Rs. 12,000 crore, is partnering with Shankara Eye Foundation to build a 225 bed hospital in Panvel. The hospital will provide eyecare and surgeries free of charge to patients, Jhunjhunwala announced.
The idea, Jhunjhunwala told CNBCTV18, came from another investor, Ashish Kacholia, who along with his family, does significant charitable work (this is something that the famously reclusive Kacholia has not spoken publicly about). Jhunjhunwala got the idea of an eye hospital from Kacholia's father. One third of the world's blind live in India, and Jhunjhunwala said he intends to build more such hospitals if the first one is a success. Jhunjhunwala added that he was building the hospital in tribute to his father, who funded cataract operations for poor patients.
The focus of superstar shareholders in the media tends to be big names like Rakesh Jhunjhunwala, but there are other large shareholders with interesting, diverse portfolios and large holdings. Here we compare Rakesh Jhunjhunwala and Dolly Khanna's portfolios.
Dolly Khanna's portfolio, as of the latest numbers, have four of 25 stocks in the portfolio that are sharp underperformers, but over ten stocks have provided over triple-digit returns in the past year (although three of these - Aksharchem, Rain Industries and Shreyans - are recent investments)
Rakesh Jhunjhunwala's portfolio has seen 10 out of 25 stocks that have underperformed, with either single digit or negative returns. In the portfolio, five of 32 stocks that have seen over triple digit returns in the last year.
What is also interesting is how different the focus of these two portfolios are. Dolly Khanna's portfolio has multiple investments in sectors like sugar, which Jhunjhunwala doesn't have an investment in. Sugar companies saw a big boost in terms of regulation over the last year, with the government limiting imports to protect prices for Indian players. Dolly Khanna also invested in plastic, yarn, chemicals and other old school industries.
Jhunjhunwala on the other hand prefers companies in his portfolio that are in pharma, finance - HFCs and Banks - tech and the retail sector, companies that rely more on the health of export markets, the urban ecosystem and growth of India's middle class consumer base. It will be interesting to see how these portfolios change over the coming months as these investors look at new macroeco numbers and make fresh bets.
Rakesh Jhunjhunwala is taking contra bets and making a killing out of itSeveral of Jhunjhunwala's portfolio stocks have hit the bull's eye this year, half of them have climbed over 60% and four of them doubled their stock prices.
As per corporate shareholdings filed for June 30, 2017, Rakesh Jhunjhunwala holds 32 stocks with a net worth of over Rs. 11,106.05 crore. Jhunjhunwala's portfolio has changed a fair amount in the June and March quarters.
To understand the portfolio shifts, we compiled an analysis below. We look at Jhunjhunwala's investments in terms of the stocks where he increased his stake or made new investments, and where he has decreased his stake.
The dominant sector in Jhunjhunwala's new and increased investments for the June quarter is healthcare and pharma - three pharma companies, one healthcare supplies firm. He was the only investor to increase his stake in pharma company Lupin after weak results (see table). He also bought or increased stakes in Jaiprakash Associates and agrochemical firm Rallis India.
Interestingly, one of the companies where Jhunjhunwala reduced stake in the June quarter, Prakash Industries, is part of our Best Bargains screener after its June results, and hit a new year high in share price in the past week.
Jhunjhunwala has a couple of companies in his portfolio where he increased his stake during the March quarter, and then decreased in the June quarter: BPO company FirstSource Solutions and jewelery and appliances firm Titan. These are highlighted in yellow in the tables below.
The stocks Jhunjhunwala, 4 other ace investors are buying or sellingHere's a look at what Rakesh Jhunjhunwala, Ashish Kacholia, Anil Kumar Goel and Dolly Khanna have bought and sold in the quarter ended June.